NO764182L - - Google Patents
Info
- Publication number
- NO764182L NO764182L NO764182A NO764182A NO764182L NO 764182 L NO764182 L NO 764182L NO 764182 A NO764182 A NO 764182A NO 764182 A NO764182 A NO 764182A NO 764182 L NO764182 L NO 764182L
- Authority
- NO
- Norway
- Prior art keywords
- approx
- sodium salt
- cefacetril
- solution
- aqueous
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 33
- 239000013078 crystal Substances 0.000 claims description 25
- -1 cefacetril sodium salt Chemical class 0.000 claims description 18
- RRYMAQUWDLIUPV-BXKDBHETSA-N cefacetrile Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC#N)[C@@H]12 RRYMAQUWDLIUPV-BXKDBHETSA-N 0.000 claims description 15
- 159000000000 sodium salts Chemical class 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 11
- 230000008025 crystallization Effects 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 238000002441 X-ray diffraction Methods 0.000 claims description 7
- 235000017281 sodium acetate Nutrition 0.000 claims description 7
- 238000001228 spectrum Methods 0.000 claims description 7
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 229940087562 sodium acetate trihydrate Drugs 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- GXCRUTWHNMMJEK-WYUVZMMLSA-M Cefacetrile sodium Chemical class [Na+].S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CC#N)[C@@H]12 GXCRUTWHNMMJEK-WYUVZMMLSA-M 0.000 claims 3
- 230000004048 modification Effects 0.000 description 39
- 238000012986 modification Methods 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000013543 active substance Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005056 compaction Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 206010005940 Bone and joint infections Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000004279 X-ray Guinier Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229960003972 cefacetrile Drugs 0.000 description 1
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/28—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1597475 | 1975-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO764182L true NO764182L (ko) | 1977-06-10 |
Family
ID=4413483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO764182A NO764182L (ko) | 1975-12-09 | 1976-12-08 |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US4061853A (ko) |
| JP (1) | JPS5270012A (ko) |
| AR (1) | AR210185A1 (ko) |
| AT (1) | AT348676B (ko) |
| AU (1) | AU503493B2 (ko) |
| BE (1) | BE849160A (ko) |
| BG (1) | BG24818A3 (ko) |
| CA (1) | CA1065855A (ko) |
| CS (1) | CS188297B2 (ko) |
| DD (1) | DD127277A5 (ko) |
| DE (1) | DE2655130C3 (ko) |
| DK (1) | DK550276A (ko) |
| EG (1) | EG12407A (ko) |
| ES (1) | ES454023A1 (ko) |
| FI (1) | FI763504A (ko) |
| FR (1) | FR2334685A1 (ko) |
| GB (1) | GB1561060A (ko) |
| GR (1) | GR73008B (ko) |
| HU (1) | HU176213B (ko) |
| IE (1) | IE44319B1 (ko) |
| IL (1) | IL51067A (ko) |
| NL (1) | NL7613712A (ko) |
| NO (1) | NO764182L (ko) |
| NZ (1) | NZ182832A (ko) |
| OA (1) | OA05502A (ko) |
| PH (1) | PH11990A (ko) |
| PL (1) | PL104763B1 (ko) |
| PT (1) | PT65932B (ko) |
| RO (1) | RO70871A (ko) |
| SE (1) | SE7613802L (ko) |
| SU (1) | SU657750A3 (ko) |
| YU (1) | YU297976A (ko) |
| ZA (1) | ZA767330B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132848A (en) * | 1977-11-03 | 1979-01-02 | Eli Lilly And Company | Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration |
| IT1214587B (it) * | 1986-12-23 | 1990-01-18 | Giovanni Bonfanti | Metodo per la produzione diprodotti cristallini puri. |
| JP3266395B2 (ja) * | 1993-11-24 | 2002-03-18 | 富士写真フイルム株式会社 | 有機薬品の晶析方法 |
| USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH480365A (de) * | 1965-01-18 | 1969-10-31 | Ciba Geigy | Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure |
-
1976
- 1976-11-01 US US05/737,376 patent/US4061853A/en not_active Expired - Lifetime
- 1976-11-17 RO RO7688475A patent/RO70871A/ro unknown
- 1976-11-27 EG EG76735A patent/EG12407A/xx active
- 1976-11-29 AR AR265653A patent/AR210185A1/es active
- 1976-12-03 OA OA56003A patent/OA05502A/xx unknown
- 1976-12-04 DE DE2655130A patent/DE2655130C3/de not_active Expired
- 1976-12-06 PT PT65932A patent/PT65932B/pt unknown
- 1976-12-06 PH PH19205A patent/PH11990A/en unknown
- 1976-12-07 BG BG7600034852A patent/BG24818A3/xx unknown
- 1976-12-07 FI FI763504A patent/FI763504A/fi not_active Application Discontinuation
- 1976-12-07 DD DD196175A patent/DD127277A5/xx unknown
- 1976-12-07 AT AT904776A patent/AT348676B/de not_active IP Right Cessation
- 1976-12-07 GB GB50970/76A patent/GB1561060A/en not_active Expired
- 1976-12-07 FR FR7636781A patent/FR2334685A1/fr active Granted
- 1976-12-07 ES ES454023A patent/ES454023A1/es not_active Expired
- 1976-12-07 SU SU762426141A patent/SU657750A3/ru active
- 1976-12-07 GR GR52337A patent/GR73008B/el unknown
- 1976-12-07 HU HU76CI1701A patent/HU176213B/hu unknown
- 1976-12-07 CA CA267,272A patent/CA1065855A/en not_active Expired
- 1976-12-08 ZA ZA767330A patent/ZA767330B/xx unknown
- 1976-12-08 AU AU20364/76A patent/AU503493B2/en not_active Expired
- 1976-12-08 NZ NZ182832A patent/NZ182832A/xx unknown
- 1976-12-08 CS CS768023A patent/CS188297B2/cs unknown
- 1976-12-08 IE IE2684/76A patent/IE44319B1/en unknown
- 1976-12-08 PL PL1976194233A patent/PL104763B1/pl unknown
- 1976-12-08 DK DK550276A patent/DK550276A/da unknown
- 1976-12-08 YU YU02979/76A patent/YU297976A/xx unknown
- 1976-12-08 SE SE7613802A patent/SE7613802L/ not_active Application Discontinuation
- 1976-12-08 BE BE173041A patent/BE849160A/xx unknown
- 1976-12-08 NO NO764182A patent/NO764182L/no unknown
- 1976-12-08 IL IL7651067A patent/IL51067A/xx unknown
- 1976-12-09 NL NL7613712A patent/NL7613712A/xx not_active Application Discontinuation
- 1976-12-09 JP JP51147183A patent/JPS5270012A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4822807A (en) | Pharmaceutical composition containing a stable modification of torasemide | |
| CH638680A5 (de) | Verfahren zur herstellung einer injizierbaren waessrigen loesung eines cephalosporinantibiotikums. | |
| US2446102A (en) | Complex salts of streptomycin and process for preparing same | |
| JPH029885A (ja) | セファロスポリン塩および注射可能な組成物 | |
| KR100403256B1 (ko) | 결정성n-아세틸뉴라민산유도체및그제조방법 | |
| JPS6145626B2 (ko) | ||
| EP0280157B1 (de) | Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung | |
| SU847922A3 (ru) | Способ получени - - -( -окси- -метил-НиКОТиНАМидО)- -( -ОКСифЕНил)АцЕТАМидО - -( -МЕТилТЕТРАзОл- -ил)ТиОМЕТил- -цЕфЕМ- -КАРбОНОВОй КиСлОТы | |
| JPS6020394B2 (ja) | 抗生物質の製造方法 | |
| DE2614669C2 (de) | Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung | |
| NO764182L (ko) | ||
| NO154015B (no) | Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat. | |
| US4104470A (en) | Crystallization process for cefazolin sodium | |
| US6703410B1 (en) | Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide | |
| US4902789A (en) | Process and composition for the purification of amphotericin B | |
| EP0643058B1 (en) | Crystals of an antimicrobial compound | |
| EP0297019B1 (en) | Famotidine polymorphic form and preparation thereof | |
| CS195746B2 (en) | Process for preparing crystalline methanolate of natrium salt of cephamandole | |
| EP0094639B1 (en) | Sodium 7-beta-(2d-2-amino-2-carboxyethylthioacetamido)-7-alpha-methoxy-3-(1-methyl-1h-tetrazol-5-yl)-thiomethyl-3-cephem-4-carboxylate heptahydrate, process for its preparation as well as pharmaceutical compositions containing same | |
| JP5960460B2 (ja) | 結晶性レボホリン酸及びその調製方法 | |
| JP2575590B2 (ja) | トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法 | |
| JP2572563B2 (ja) | セファロスポリン中間生成物の新規安定な結晶形 | |
| JP2621392B2 (ja) | Ｎ―（１ｈ―テトラゾール―５―イルノ―１―フェノキシ―４ｈ―キノリジン―４―オン―３―カルボキサミド・ナトリウム塩の結晶性ノ水和物 | |
| EP0039967A1 (en) | Solvate of amoxicillin, process for the preparation thereof and process for the preparation of injectable preparations from this solvate | |
| JPS6052716B2 (ja) | 抗生物質 |